Jacob (Jake) Rubens, Ph.D., is an Origination Partner at Flagship Pioneering. He is a scientist entrepreneur and leads a Pioneering Business Unit that founds and grows companies based on new biotechnology. At Flagship, Jake co-founded Quotient Therapeutics, Tessera Therapeutics, and Sana Biotechnology, and launched Kaleido Biosciences. Jake is currently the CEO of a stealth company developing a breakthrough technology for engineering life that enables a new class of medicines. Previously, Jake was Co-Founder and Chief Executive Officer of Quotient; Co-founder, Chief Scientific Officer, and Chief Innova...read more